Developer docs
API playgroundTry for free, no card

Search company profiles

Sleep Services Australia

Full company profile

uuid0027ob4

Namestring
Sleep Services Australia
Legal namestring
Sleep Services Australia
Company typeenum
Private
Founded yearstring
-
Short descriptiontext

Sleep Services Australia provides Level 2 Sleep Study diagnostic testing for sleep apnoea, snoring, and insomnia. It serves individual patients and referring physicians in Australia, with reports signed by specialist physicians. The company was acquired by CardioScan in 2024.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHawthorn, Australia
HQ citystring
Hawthorn
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sleep diagnostic services, home sleep studies, sleep apnea testing, sleep disorder diagnosis, respiratory sleep medicine
Industry3 codes
PRIMARYHLAFAKAF
Sleep Diagnostic Centers (Polysomnography)
SECONDARYHLAHAGAB
Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAFABAJ
Ambulatory Sleep Medicine Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
NAICS code1 code
  • Home Health Care Services62161
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Sleep Diagnostic Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Sleep Diagnostic Services
TypeProfessional Services
Description

Sleep Services Australia provides Level 2 Sleep Study diagnostic tests. Following its acquisition by CardioScan, the company operates within CardioScan's global cardiac diagnostics network that serves over 800,000 patients annually across 11 countries.

sleepservices.com.au
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Sleep Services Australia provides Level 2 Sleep Studies—home-based diagnostic sleep tests that monitor physiological parameters such as breathing, oxygen levels, and heart rate during sleep. Tests are reported through CardioScan's clinical infrastructure, with all reports reviewed and signed off by a Sleep and Respiratory Physician and returned within 10 business days. The service is targeted at individuals suspected of having sleep apnoea, snoring, insomnia, or related sleep disorders.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Reports available in 10 business days
Product and service1 record
1Level 2 Sleep Studies
CategorySleep Diagnostics
Description

Comprehensive home-based Level 2 Sleep Study diagnostic testing that monitors breathing, oxygen levels, heart rate, and other physiological parameters during sleep. Designed for patients with suspected sleep apnoea, snoring, or insomnia, and for healthcare providers who refer patients for diagnosis. All reports are reviewed and signed off by a Sleep and Respiratory Physician and delivered within 10 business days.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1CardioScan
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sleep Services Australia has joined CardioScan, a global leader in cardiac diagnostics. CardioScan provides clinical reporting for more than 800,000 patients each year across 11 countries. In Australia, CardioScan provides Level 2 Sleep Studies, with all reports signed off by a Sleep and Respiratory Physician and available in 10 business days. Sleep Services Australia now operates as part of CardioScan's Australian operations.

sleepservices.com.au
Peers10 records
TypeDirect peer
Description

Compumedics is an Australian-headquartered medical device company that develops and sells sleep diagnostic systems (polysomnography and home sleep testing devices). It is one of the closest Australian-based comparables for sleep diagnostic technology and services.

TypeBroad incumbent
Description

ResMed is a global leader in sleep apnea and respiratory care, with both diagnostic and therapy products. While primarily a CPAP/therapy incumbent, its connected sleep ecosystem overlaps with the diagnostic pathway.

TypeRegional player
Description

SomnoMed is an Australia-headquartered medical device company focused on oral appliance therapy for obstructive sleep apnea. While focused on treatment rather than diagnostics, it serves the same Australian sleep disorder patient population and is a regional peer in the sleep care value chain.

TypeDirect peer
Description

Itamar Medical (a subsidiary of ZOLL Medical) produces the WatchPAT home sleep testing device and related diagnostic services for sleep apnea. It is a direct peer in the home-based sleep diagnostic category.

TypeDirect peer
Description

SleepMed operates sleep diagnostic centers and home sleep testing services in the United States. It is a direct comparable in clinical sleep diagnostics with physician-interpreted reporting.

TypeDirect peer
Description

VirtuOx is a US-based provider of home sleep testing services for diagnosing obstructive sleep apnea, with a direct-to-patient and B2B2C model comparable to Sleep Services Australia.

TypeDirect peer
Description

Nox Medical manufactures and supplies polysomnography and home sleep testing equipment and software used by sleep diagnostic providers globally. It is a direct comparable on the technology stack underpinning Level 2 Sleep Studies.

TypeDirect peer
Description

CleveMed develops wireless home sleep testing and portable monitoring devices, including the SleepView system. It directly competes in the home-based Level 2/3 sleep diagnostic space.

TypeBroad incumbent
Description

Philips operates a broad sleep and respiratory care portfolio, including sleep diagnostic solutions and CPAP therapy. It is a broad incumbent whose offerings overlap with home sleep testing and downstream sleep apnea management.

10CardioScan
TypeBroad incumbent
Description

CardioScan is the parent company and global cardiac diagnostics provider serving 800,000+ patients across 11 countries. Sleep Services Australia's Level 2 Sleep Studies are now delivered through CardioScan's clinical infrastructure and reporting systems.

Market position
Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sleep Services Australia

Sleep Diagnostic Servicessleepservices.com.au

Sleep Services Australia provides Level 2 Sleep Study diagnostic testing for sleep apnoea, snoring, and insomnia. It serves individual patients and referring physicians in Australia, with reports signed by specialist physicians. The company was acquired by CardioScan in 2024.

Sleep Services Australia firmographics

Firmographics
Name
Sleep Services Australia
Legal name
Sleep Services Australia
Website
https://sleepservices.com.au
Company type
Private
Operating status
Acquired
Headcount range
1–10 employees
Short description
Sleep Services Australia provides Level 2 Sleep Study diagnostic testing for sleep apnoea, snoring, and insomnia. It serves individual patients and referring physicians in Australia, with reports signed by specialist physicians. The company was acquired by CardioScan in 2024.
Ownership category
akta.pro rank

Sleep Services Australia industry classification

Industry
Product category
Sleep Diagnostic Services
NAICS
Home Health Care Services (62161)
SIC
Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAFAKAF
Sleep Diagnostic Centers (Polysomnography)
SECONDARYHLAHAGAB
Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAFABAJ
Ambulatory Sleep Medicine Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

Keywords

  • Sleep diagnostic services
  • Home sleep studies
  • Sleep apnea testing
  • Sleep disorder diagnosis
  • Respiratory sleep medicine

Where Sleep Services Australia is headquartered

Location

Headquarters

HQ city
Hawthorn
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Sleep Services Australia business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Sleep Diagnostic Services: Sleep Services Australia provides Level 2 Sleep Study diagnostic tests. Following its acquisition by CardioScan, the company operates within CardioScan's global cardiac diagnostics network that serves over 800,000 patients annually across 11 countries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Sleep Services Australia product offering

Product offering

Core offering

Sleep Services Australia provides Level 2 Sleep Studies—home-based diagnostic sleep tests that monitor physiological parameters such as breathing, oxygen levels, and heart rate during sleep. Tests are reported through CardioScan's clinical infrastructure, with all reports reviewed and signed off by a Sleep and Respiratory Physician and returned within 10 business days. The service is targeted at individuals suspected of having sleep apnoea, snoring, insomnia, or related sleep disorders.

Differentiator

Problem solved

Functional benefit

Products and services

  • Level 2 Sleep Studies Comprehensive home-based Level 2 Sleep Study diagnostic testing that monitors breathing, oxygen levels, heart rate, and other physiological parameters during sleep. Designed for patients with suspected sleep apnoea, snoring, or insomnia, and for healthcare providers who refer patients for diagnosis. All reports are reviewed and signed off by a Sleep and Respiratory Physician and delivered within 10 business days.

Quantifiable outcome

  • Reports available in 10 business days

Companies that use Sleep Services Australia

Customer profile

Segments2 records

Ideal customer profiles2 records

Sleep Services Australia technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Sleep Services Australia partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CardioScancoreStrategic or Co-development PartnerSleep Services Australia has joined CardioScan, a global leader in cardiac diagnostics. CardioScan provides clinical reporting for more than 800,000 patients each year across 11 countries. In Australia, CardioScan provides Level 2 Sleep Studies, with all reports signed off by a Sleep and Respiratory Physician and available in 10 business days. Sleep Services Australia now operates as part of CardioScan's Australian operations.

Scale indicators3 records

Sleep Services Australia competitors and assessment

Company assessment

Direct peers

  • Compumedics: Compumedics is an Australian-headquartered medical device company that develops and sells sleep diagnostic systems (polysomnography and home sleep testing devices). It is one of the closest Australian-based comparables for sleep diagnostic technology and services.
  • Itamar Medical: Itamar Medical (a subsidiary of ZOLL Medical) produces the WatchPAT home sleep testing device and related diagnostic services for sleep apnea. It is a direct peer in the home-based sleep diagnostic category.
  • SleepMed: SleepMed operates sleep diagnostic centers and home sleep testing services in the United States. It is a direct comparable in clinical sleep diagnostics with physician-interpreted reporting.
  • VirtuOx: VirtuOx is a US-based provider of home sleep testing services for diagnosing obstructive sleep apnea, with a direct-to-patient and B2B2C model comparable to Sleep Services Australia.
  • Nox Medical: Nox Medical manufactures and supplies polysomnography and home sleep testing equipment and software used by sleep diagnostic providers globally. It is a direct comparable on the technology stack underpinning Level 2 Sleep Studies.
  • CleveMed: CleveMed develops wireless home sleep testing and portable monitoring devices, including the SleepView system. It directly competes in the home-based Level 2/3 sleep diagnostic space.

Broad incumbents

  • ResMed: ResMed is a global leader in sleep apnea and respiratory care, with both diagnostic and therapy products. While primarily a CPAP/therapy incumbent, its connected sleep ecosystem overlaps with the diagnostic pathway.
  • Phillips Sleep & Respiratory Care: Philips operates a broad sleep and respiratory care portfolio, including sleep diagnostic solutions and CPAP therapy. It is a broad incumbent whose offerings overlap with home sleep testing and downstream sleep apnea management.
  • CardioScan: CardioScan is the parent company and global cardiac diagnostics provider serving 800,000+ patients across 11 countries. Sleep Services Australia's Level 2 Sleep Studies are now delivered through CardioScan's clinical infrastructure and reporting systems.

Regional players

  • SomnoMed: SomnoMed is an Australia-headquartered medical device company focused on oral appliance therapy for obstructive sleep apnea. While focused on treatment rather than diagnostics, it serves the same Australian sleep disorder patient population and is a regional peer in the sleep care value chain.

Market position

Customer concentration

Sleep Services Australia social profiles

Digital presence

Sleep Services Australia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sleep Services Australia leadership team

Management profile

Number of profiles

Sleep Services Australia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sleep Services Australia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sleep Services Australia

What does Sleep Services Australia do?

Sleep Services Australia provides Level 2 Sleep Studies—home-based diagnostic sleep tests that monitor physiological parameters such as breathing, oxygen levels, and heart rate during sleep. Tests are reported through CardioScan's clinical infrastructure, with all reports reviewed and signed off by a Sleep and Respiratory Physician and returned within 10 business days. The service is targeted at individuals suspected of having sleep apnoea, snoring, insomnia, or related sleep disorders.

Is Sleep Services Australia a public or private company?

Sleep Services Australia is a private company. It is classified as corporate owned and is currently acquired.

When was Sleep Services Australia founded?

Sleep Services Australia was founded in -1. It employs 1 to 10 people.

Where is Sleep Services Australia based?

Sleep Services Australia is headquartered in Hawthorn, Australia, in the Oceania region.

How does Sleep Services Australia make money?

One revenue line is on record: sleep Diagnostic Services.

Who are Sleep Services Australia's main competitors?

Direct peers on record are Compumedics, Itamar Medical, SleepMed, VirtuOx, Nox Medical and CleveMed. Broad incumbents are ResMed, Phillips Sleep & Respiratory Care and CardioScan. SomnoMed is listed as a regional player.

Does Sleep Services Australia have an API?

No public API is recorded for Sleep Services Australia.

What industry is Sleep Services Australia in?

Sleep Services Australia's product category is Sleep Diagnostic Services. Its primary akta.pro industry code is HLAFAKAF, Sleep Diagnostic Centers (Polysomnography), with a secondary code of HLAHAGAB, Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy). Its NAICS code is 62161 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales